These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 127526)

  • 1. Fibrin powder turbidity measurement for rapid assessment of antiplasmins.
    Exner T; Rickard KA; Kronenberg H
    Am J Clin Pathol; 1975 Nov; 64(5):597-601. PubMed ID: 127526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative activities of amino acid and polypeptide inhibitors on natural and synthetic substrates.
    Skoza L; Tse AO; Semar M; Johnson AJ
    Ann N Y Acad Sci; 1968 Jun; 146(2):659-72. PubMed ID: 4239440
    [No Abstract]   [Full Text] [Related]  

  • 3. [FIBRINOLYSIS AND ANTIFIBRINOLYTIC THERAPY IN UROLOGIC OPERATIONS. EXAMINATIONS USING A NEW METHOD FOR MEASURING FIBRINOLYSIS].
    PIPER W; BUCHBERGER HG; SIMON S; KRUEGER J
    Med Welt; 1965 Feb; 8():385-96. PubMed ID: 14262868
    [No Abstract]   [Full Text] [Related]  

  • 4. [Molecular mechanisms of fibrinolysis and perspectives of thrombolytic therapy].
    Veremeenko KN; Kizim AI
    Vopr Med Khim; 1984; 30(5):13-22. PubMed ID: 6084892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coagulation and fibrinolytic studies following use of proteinase inhibitors in prostatic surgery.
    Phillips LL; Weiss R; Wolf C
    Ann N Y Acad Sci; 1968 Jun; 146(2):737-44. PubMed ID: 4239442
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparative studies of fibrinolytic inhibitors in vitro.
    Maki M; Beller FK
    Thromb Diath Haemorrh; 1966 Dec; 16(3):668-86. PubMed ID: 4231539
    [No Abstract]   [Full Text] [Related]  

  • 7. Experimental defibrination and bothropase: a study on the fibrinolytic mechanism in vivo.
    Kelen EM; Rosenfeld G; Vainzof M; Machado ZC
    Haemostasis; 1978; 7(1):35-45. PubMed ID: 147812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ON THE INTERACTION OF FIBRINOLYSIN (PLASMIN) WITH THE INHIBITORS ANTIFIBRINOLYSIN AND SOYBEAN TRYPSIN INHIBITOR.
    NANNINGA LB; GUEST MM
    Arch Biochem Biophys; 1964 Dec; 108():542-51. PubMed ID: 14244698
    [No Abstract]   [Full Text] [Related]  

  • 9. [ANTIPLASMIN ACTIVITY OF THE PANCREATIC TRYPSIN INHIBITOR AND OF EPSILON-AMINOCAPROIC ACID].
    DEBARBIERI A; SCEVOLA ME; FRANCHINI M
    Boll Chim Farm; 1964 Jan; 103():37-40. PubMed ID: 14131376
    [No Abstract]   [Full Text] [Related]  

  • 10. Plasminogen-plasmin system. VII. Potentiation of antifibrinolytic action of a synthetic inhibitor, tranexamic acid, by alpha 2-macroglobulin antiplasmin.
    Abiko Y; Iwamoto M
    Biochim Biophys Acta; 1970 Sep; 214(3):411-8. PubMed ID: 4251764
    [No Abstract]   [Full Text] [Related]  

  • 11. [Ultra-micro-determination of plasmin using a fibrin plate. 3. Relationship to antiplasmin agents].
    Miyatani K; Fukui I
    Rinsho Byori; 1971 Dec; 19(12):859-62. PubMed ID: 4258880
    [No Abstract]   [Full Text] [Related]  

  • 12. Alpha-2 plasmin inhibitor-plasmin complex and postoperative blood loss: double-blind study with aprotinin in reoperation for myocardial revascularization.
    Minami K; Notohamiprodjo G; Buschler H; Prohaska W; Reichelt W; Körfer R
    J Thorac Cardiovasc Surg; 1993 Nov; 106(5):934-6. PubMed ID: 7694000
    [No Abstract]   [Full Text] [Related]  

  • 13. Studies on the mechanisms of action of aprotinin and tranexamic acid as plasmin inhibitors and antifibrinolytic agents.
    Longstaff C
    Blood Coagul Fibrinolysis; 1994 Aug; 5(4):537-42. PubMed ID: 7531000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies on the mechanism of action of synthetic antifibrinolytics. A comparison with the action of derivatives of benzamidine on the fibrinolytic process.
    Landmann H
    Thromb Diath Haemorrh; 1973 May; 29(2):253-75. PubMed ID: 4271586
    [No Abstract]   [Full Text] [Related]  

  • 15. Fibrin formation and dissolution in women receiving oral contraceptive drugs.
    Ball AP; McKee PA
    J Lab Clin Med; 1977 Apr; 89(4):751-62. PubMed ID: 845477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mafenide (Sulfamylon) inhibits plasmin fibrinolytic activity.
    Weisdorf DJ; Aldridge JH
    Thromb Haemost; 1988 Jun; 59(3):440-4. PubMed ID: 2973151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional characterization of a slow and tight-binding inhibitor of plasmin isolated from Russell's viper venom.
    Cheng AC; Tsai IH
    Biochim Biophys Acta; 2014 Jan; 1840(1):153-9. PubMed ID: 23999090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Measurements of plasmin-alpha 2 plasmin inhibitor complex and FDP.D dimer levels in the fibrinolytic therapy of acute pulmonary thromboembolism].
    Yamasawa F; Hasegawa N; Asano K; Sayama K; Fujita H; Urano T; Aoki T; Ishizaka A; Kanazawa M; Kawashiro T
    Kokyu To Junkan; 1992 Jul; 40(7):685-90. PubMed ID: 1387724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complete inhibition of fibrinolysis by sustained carboxypeptidase B activity: the role and requirement of plasmin inhibitors.
    Walker JB; Bajzar L
    J Thromb Haemost; 2007 Jun; 5(6):1257-64. PubMed ID: 17389009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent advances on plasmin inhibitors for the treatment of fibrinolysis-related disorders.
    Al-Horani RA; Desai UR
    Med Res Rev; 2014 Nov; 34(6):1168-216. PubMed ID: 24659483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.